{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T11:36:46Z","timestamp":1786534606041,"version":"build-2736575974"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nutr"],"DOI":"10.1186\/s40795-026-01343-y","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T18:47:03Z","timestamp":1780426023000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of folic acid on homocysteine and cardiovascular surrogate biomarkers in hyperhomocysteinemia: a systematic review and meta-analysis of RCTs"],"prefix":"10.1186","volume":"12","author":[{"given":"Zhi-ping","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan-fan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-bo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-zhen","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"issue":"6","key":"1343_CR1","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.ejim.2014.04.011","volume":"25","author":"CY Wang","year":"2014","unstructured":"Wang CY, Chen ZW, Zhang T, Liu J, Chen SH, Liu SY, Han LY, Hui ZH, Chen YM. Elevated plasma homocysteine level is associated with ischemic stroke in Chinese hypertensive patients. Eur J Intern Med. 2014;25(6):538\u201344.","journal-title":"Eur J Intern Med"},{"issue":"8","key":"1343_CR2","first-page":"Cd006612","volume":"8","author":"AJ Mart\u00ed-Carvajal","year":"2017","unstructured":"Mart\u00ed-Carvajal AJ, Sol\u00e0 I, Lathyris D, Dayer M. Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev. 2017;8(8):Cd006612.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"1343_CR3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1080\/01616412.2022.2159137","volume":"45","author":"W Liu","year":"2023","unstructured":"Liu W, Ma XL, Gu HQ, Li H, Li ZX, Wang YJ. Elevated levels of total homocysteine after ischemic stroke: a potential marker for in-hospital outcomes. Neurol Res. 2023;45(6):497\u2013504.","journal-title":"Neurol Res"},{"issue":"5","key":"1343_CR4","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1093\/ajcn\/70.5.881","volume":"70","author":"A Chait","year":"1999","unstructured":"Chait A, Malinow MR, Nevin DN, Morris CD, Eastgard RL, Kris-Etherton P, Pi-Sunyer FX, Oparil S, Resnick LM, Stern JS, Haynes RB, Hatton DC, Metz JA, Clark S, McMahon M, Holcomb S, Reusser ME, Snyder GW, McCarron DA. Increased dietary micronutrients decrease serum homocysteine concentrations in patients at high risk of cardiovascular disease. Am J Clin Nutr. 1999;70(5):881\u20137.","journal-title":"Am J Clin Nutr"},{"issue":"13","key":"1343_CR5","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1001\/jama.1995.03530130055028","volume":"274","author":"CJ Boushey","year":"1995","unstructured":"Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA. 1995;274(13):1049\u201357.","journal-title":"JAMA"},{"key":"1343_CR6","doi-asserted-by":"publisher","first-page":"579","DOI":"10.5604\/17322693.1102340","volume":"68","author":"A Baszczuk","year":"2014","unstructured":"Baszczuk A, Kopczy\u0144ski Z. [Hyperhomocysteinemia in patients with cardiovascular disease]. Postepy Hig Med Dosw (Online). 2014;68:579\u201389.","journal-title":"Postepy Hig Med Dosw (Online)"},{"issue":"12","key":"1343_CR7","first-page":"743","volume":"14","author":"Y Yao","year":"2017","unstructured":"Yao Y, Gao LJ, Zhou Y, Zhao JH, Lv Q, Dong JZ, Shang MS. Effect of advanced age on plasma homocysteine levels and its association with ischemic stroke in non-valvular atrial fibrillation. J Geriatr Cardiol. 2017;14(12):743\u20139.","journal-title":"J Geriatr Cardiol"},{"issue":"5","key":"1343_CR8","doi-asserted-by":"publisher","first-page":"363","DOI":"10.7326\/0003-4819-131-5-199909070-00008","volume":"131","author":"JW Eikelboom","year":"1999","unstructured":"Eikelboom JW, Lonn E, Genest J Jr., Hankey G, Yusuf S. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med. 1999;131(5):363\u201375.","journal-title":"Ann Intern Med"},{"issue":"2","key":"1343_CR9","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1161\/01.STR.0000115161.10646.67","volume":"35","author":"FM Faraci","year":"2004","unstructured":"Faraci FM, Lentz SR. Hyperhomocysteinemia, oxidative stress, and cerebral vascular dysfunction. Stroke. 2004;35(2):345\u20137.","journal-title":"Stroke"},{"issue":"2","key":"1343_CR10","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.clnu.2013.01.001","volume":"32","author":"C Zhou","year":"2013","unstructured":"Zhou C, Wu J, Fang S. Meta-analysis of B vitamin supplementation on plasma homocysteine, cardiovascular and all-cause mortality. Clin Nutr. 2013;32(2):314.","journal-title":"Clin Nutr"},{"issue":"1","key":"1343_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/nutrit\/nuw053","volume":"75","author":"AE Stanhewicz","year":"2017","unstructured":"Stanhewicz AE, Kenney WL. Role of folic acid in nitric oxide bioavailability and vascular endothelial function. Nutr Rev. 2017;75(1):61\u201370.","journal-title":"Nutr Rev"},{"key":"1343_CR12","doi-asserted-by":"publisher","first-page":"e3533","DOI":"10.1136\/bmj.e3533","volume":"344","author":"MJ Jardine","year":"2012","unstructured":"Jardine MJ, Kang A, Zoungas S, Navaneethan SD, Ninomiya T, Nigwekar SU, Gallagher MP, Cass A, Strippoli G, Perkovic V. The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis. BMJ. 2012;344:e3533.","journal-title":"BMJ"},{"issue":"5","key":"1343_CR13","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.clnu.2012.12.009","volume":"32","author":"X Qin","year":"2013","unstructured":"Qin X, Huo Y, Xie D, Hou F, Xu X, Wang X. Homocysteine-lowering therapy with folic acid is effective in cardiovascular disease prevention in patients with kidney disease: a meta-analysis of randomized controlled trials. Clin Nutr. 2013;32(5):722\u20137.","journal-title":"Clin Nutr"},{"issue":"9","key":"1343_CR14","doi-asserted-by":"publisher","first-page":"e25142","DOI":"10.1371\/journal.pone.0025142","volume":"6","author":"YH Zhou","year":"2011","unstructured":"Zhou YH, Tang JY, Wu MJ, Lu J, Wei X, Qin YY, Wang C, Xu JF, He J. Effect of folic acid supplementation on cardiovascular outcomes: a systematic review and meta-analysis. PLoS ONE. 2011;6(9):e25142.","journal-title":"PLoS ONE"},{"issue":"2","key":"1343_CR15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1542-4758.2007.00171.x","volume":"11","author":"AC Vianna","year":"2007","unstructured":"Vianna AC, Mocelin AJ, Matsuo T, Morais-Filho D, Largura A, Delfino VA, Soares AE, Matni AM. Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events. Hemodial Int. 2007;11(2):210\u20136.","journal-title":"Hemodial Int"},{"issue":"15","key":"1343_CR16","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1056\/NEJMoa055227","volume":"354","author":"KH B\u00f8naa","year":"2006","unstructured":"B\u00f8naa KH, Nj\u00f8lstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E, Rasmussen K. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med. 2006;354(15):1578\u201388.","journal-title":"N Engl J Med"},{"key":"1343_CR17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12986-017-0233-z","volume":"14","author":"A Kumar","year":"2017","unstructured":"Kumar A, Palfrey HA, Pathak R, Kadowitz PJ, Gettys TW, Murthy SN. The metabolism and significance of homocysteine in nutrition and health. Nutr Metab (Lond). 2017;14:78.","journal-title":"Nutr Metab (Lond)"},{"issue":"16","key":"1343_CR18","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","volume":"288","author":"Homocysteine","year":"2002","unstructured":"Homocysteine. risk of ischemic heart disease and stroke: a meta-analysis. JAMA. 2002;288(16):2015\u201322.","journal-title":"JAMA"},{"issue":"7","key":"1343_CR19","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1001\/jama.300.7.795","volume":"300","author":"M Ebbing","year":"2008","unstructured":"Ebbing M, Bleie \u00d8, Ueland PM, Nordrehaug JE, Nilsen DW, Vollset SE, Refsum H, Pedersen EK, Nyg\u00e5rd O. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial. JAMA. 2008;300(7):795\u2013804.","journal-title":"JAMA"},{"issue":"24","key":"1343_CR20","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1001\/jama.2010.840","volume":"303","author":"JM Armitage","year":"2010","unstructured":"Armitage JM, Bowman L, Clarke RJ, Wallendszus K, Bulbulia R, Rahimi K, Haynes R, Parish S, Sleight P, Peto R, Collins R. Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial. JAMA. 2010;303(24):2486\u201394.","journal-title":"JAMA"},{"issue":"11","key":"1343_CR21","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","volume":"162","author":"B Hutton","year":"2015","unstructured":"Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, Ioannidis JP, Straus S, Thorlund K, Jansen JP, Mulrow C, Catal\u00e1-L\u00f3pez F, G\u00f8tzsche PC, Dickersin K, Boutron I, Altman DG, Moher D. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162(11):777\u201384.","journal-title":"Ann Intern Med"},{"key":"1343_CR22","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.","journal-title":"BMJ"},{"key":"1343_CR23","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.","journal-title":"BMJ"},{"key":"1343_CR24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1475-2891-11-2","volume":"11","author":"X Qin","year":"2012","unstructured":"Qin X, Li J, Cui Y, Liu Z, Zhao Z, Ge J, Guan D, Hu J, Wang Y, Zhang F, et al. MTHFR C677T and MTR A2756G polymorphisms and the homocysteine lowering efficacy of different doses of folic acid in hypertensive Chinese adults. Nutr J. 2012;11:2.","journal-title":"Nutr J"},{"issue":"8","key":"1343_CR25","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/jch.14697","volume":"25","author":"HH Bao","year":"2023","unstructured":"Bao HH, Huang X, Li P, Sheng CS, Zhang J, Wang ZR, Song DM, Hu LH, Ding CC, Cheng ZH, Yao C, Chen GL, Cui YM, Qin XH, Tang GF, Wang XB, Huo Y, Cheng XS, Wang JG. Combined use of amlodipine and folic acid are significantly more efficacious than amlodipine alone in lowering plasma homocysteine and blood pressure among hypertensive patients with hyperhomocysteinemia and intolerance to ACEI: A multicenter, randomized, double-blind, parallel-controlled clinical trial. J Clin Hypertens. 2023;25(8):689\u201399.","journal-title":"J Clin Hypertens"},{"issue":"3","key":"1343_CR26","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1161\/ATVBAHA.117.310211","volume":"38","author":"X Huang","year":"2018","unstructured":"Huang X, Qin X, Yang W, Liu L, Jiang C, Zhang X, Jiang S, Bao H, Su H, Li P, et al. MTHFR Gene and Serum Folate Interaction on Serum Homocysteine Lowering: prospect for Precision Folic Acid Treatment. Arterioscler Thromb Vasc Biol. 2018;38(3):679\u201385.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"1343_CR27","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.nutres.2006.08.001","volume":"26","author":"PT Lin","year":"2006","unstructured":"Lin PT, Lee BJ, Chang HH, Cheng CH, Tsai AJ, Huang YC. Low-dose folic acid supplementation reduces homocysteine concentration in hyperhomocysteinemic coronary artery disease patients. Nutr Res. 2006;26(9):460\u20136.","journal-title":"Nutr Res"},{"issue":"51","key":"1343_CR28","first-page":"E23573","volume":"99","author":"X Liu","year":"2020","unstructured":"Liu X, Tang L, Fan W, Li A, Pang J, Feng Y. The recent effects of small dose of folic acid on lipoprotein-associated phospholipase A2 and systolic blood pressure variability in coronary heart disease patients with hyperhomocysteinemia: A single-center prospective cohort study. Med (United States). 2020;99(51):E23573.","journal-title":"Med (United States)"},{"key":"1343_CR29","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.12659\/MSM.906893","volume":"24","author":"Y Peng","year":"2018","unstructured":"Peng Y, Ou BQ, Li HH, Zhou Z, Mo JL, Huang J, Liang FL. Synergistic Effect of Atorvastatin and Folic Acid on Cardiac Function and Ventricular Remodeling in Chronic Heart Failure Patients with Hyperhomocysteinemia. Med Sci Monit. 2018;24:3744\u201351.","journal-title":"Med Sci Monit"},{"issue":"18","key":"1343_CR30","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1016\/j.lfs.2004.12.002","volume":"76","author":"WHH Sheu","year":"2005","unstructured":"Sheu WHH, Chin HML, Lee WJ, Wan CJ, Su HY, Lang HF. Prospective evaluation of folic acid supplementation on plasma homocysteine concentrations during weight reduction: A randomized, double-blinded, placebo-controlled study in obese women. Life Sci. 2005;76(18):2137\u201345.","journal-title":"Life Sci"},{"issue":"7","key":"1343_CR31","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1016\/S0735-1097(99)00469-6","volume":"34","author":"KS Woo","year":"1999","unstructured":"Woo KS, Chook P, Lolin YI, Sanderson JE, Metreweli C, Celermajer DS. Folic acid improves arterial endothelial function in adults with hyperhomocystinemia. J Am Coll Cardiol. 1999;34(7):2002\u20136.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"1343_CR32","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1001\/jamainternmed.2016.4687","volume":"176","author":"X Xu","year":"2016","unstructured":"Xu X, Qin XH, Li YB, Sun DH, Wang J, Liang M, Wang BY, Huo Y, Hou FF. Csppt, Efficacy of Folic Acid Therapy on the Progression of Chronic Kidney Disease The Renal Substudy of the China Stroke Primary Prevention Trial. Jama Intern Med. 2016;176(10):1443\u201350.","journal-title":"Jama Intern Med"},{"key":"1343_CR33","doi-asserted-by":"crossref","unstructured":"Zhang S, Wang T, Wang H, Tang J, Hou A, Yan X, Yu B, Ran S, Luo M, Tang Y, Yang R, Song D, He H. Effects of individualized administration of folic acid on prothrombotic state and vascular endothelial function with H-type hypertension A double-blinded, randomized clinical cohort study. Med (United States). 2022;101(3):e28628.","DOI":"10.1097\/MD.0000000000028628"},{"issue":"6","key":"1343_CR34","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/sj.ejcn.1602778","volume":"62","author":"B Akoglu","year":"2008","unstructured":"Akoglu B, Schrott M, Bolouri H, Jaffari A, Kutschera E, Caspary WF, Faust D. The folic acid metabolite L-5-methyltetrahydrofolate effectively reduces total serum homocysteine level in orthotopic liver transplant recipients: A double-blind placebo-controlled study. Eur J Clin Nutr. 2008;62(6):796\u2013801.","journal-title":"Eur J Clin Nutr"},{"issue":"7","key":"1343_CR35","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S1053-2498(01)00240-6","volume":"20","author":"I Kutschka","year":"2001","unstructured":"Kutschka I, Pethig K, Str\u00fcber M, Dieterich C, Harringer W, Haverich A. Homocysteine - A treatable risk factor for allograft vascular disease after heart transplantation? J Heart Lung Transplant. 2001;20(7):743\u20136.","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"1343_CR36","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1093\/ndt\/15.4.524","volume":"15","author":"M Arnadottir","year":"2000","unstructured":"Arnadottir M, Gudnason V, Hultberg B. Treatment with different doses of folic acid in haemodialysis patients: effects on folate distribution and aminothiol concentrations. Nephrol Dialysis Transplantation. 2000;15(4):524\u20138.","journal-title":"Nephrol Dialysis Transplantation"},{"issue":"12","key":"1343_CR37","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1161\/01.ATV.19.12.2918","volume":"19","author":"AJ Beaulieu","year":"1999","unstructured":"Beaulieu AJ, Gohh RY, Han H, Hakas D, Jacques PF, Selhub J, Bostom AG. Enhanced reduction of fasting total homocysteine levels with supraphysiological versus standard multivitamin dose folic acid supplementation in renal transplant recipients. Arterioscler Thromb Vascular Biology. 1999;19(12):2918\u201321.","journal-title":"Arterioscler Thromb Vascular Biology"},{"issue":"3","key":"1343_CR38","first-page":"441","volume":"25","author":"SL Morgan","year":"1998","unstructured":"Morgan SL, Baggott JE, Lee JY, Alarc\u00f3n GS. Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: Implications for cardiovascular disease prevention. J Rheumatol. 1998;25(3):441\u20136.","journal-title":"J Rheumatol"},{"issue":"3\u20134","key":"1343_CR39","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1177\/0972753120925560","volume":"26","author":"UA Bhosale","year":"2019","unstructured":"Bhosale UA, Yegnanarayan R, Agrawal A, Patil A. Efficacy Study of Folic Acid Supplementation on Homocysteine Levels in Adolescent Epileptics Taking Antiepileptic Drugs: A Single Blind Randomized Controlled Clinical Trial. Annals Neurosciences. 2019;26(3\u20134):50\u20134.","journal-title":"Annals Neurosciences"},{"issue":"2","key":"1343_CR40","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1017\/S0007114599001221","volume":"82","author":"IA Brouwer","year":"1999","unstructured":"Brouwer IA, van Dusseldorp M, Duran M, Thomas CM, Hautvast JG, Eskes TK, Steegers-Theunissen RP. Low-dose folic acid supplementation does not influence plasma methionine concentrations in young non-pregnant women. Br J Nutr. 1999;82(2):85\u20139.","journal-title":"Br J Nutr"},{"issue":"10","key":"1343_CR41","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1038\/ejcn.2009.58","volume":"63","author":"A Cagnacci","year":"2009","unstructured":"Cagnacci A, Cannoletta M, Volpe A. High-dose short-term folate administration modifies ambulatory blood pressure in postmenopausal women. A placebo-controlled study. Eur J Clin Nutr. 2009;63(10):1266\u20138.","journal-title":"Eur J Clin Nutr"},{"issue":"3","key":"1343_CR42","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1054\/clnu.2002.0537","volume":"21","author":"L Potena","year":"2002","unstructured":"Potena L, Grigioni F, Magnani G, Sorbello S, Sassi S, Poci MG, Carigi S, Bacchi-Reggiani L, Leone O, Magelli C, Branzi A. Folate supplementation after heart transplantation: effects on homocysteine plasma levels and allograft vascular disease. Clin Nutr. 2002;21(3):245\u20138.","journal-title":"Clin Nutr"},{"issue":"4","key":"1343_CR43","first-page":"PI19","volume":"9","author":"M Righetti","year":"2003","unstructured":"Righetti M, Ferrario GM, Milani S, Serbelloni P, La Rosa L, Uccellini M, Sessa A. Effects of folic acid treatment on homocysteine levels and vascular disease in hemodialysis patients. Med Sci Monit. 2003;9(4):PI19\u201324.","journal-title":"Med Sci Monit"},{"issue":"8","key":"1343_CR44","doi-asserted-by":"publisher","first-page":"4622","DOI":"10.1210\/jc.2004-1954","volume":"90","author":"P Villa","year":"2005","unstructured":"Villa P, Perri C, Suriano R, Cucinelli F, Panunzi S, Ranieri M, Mele C, Lanzone A. L-folic acid supplementation in healthy postmenopausal women: effect on homocysteine and glycolipid metabolism. J Clin Endocrinol Metab. 2005;90(8):4622\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1343_CR45","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.nut.2007.01.002","volume":"23","author":"VDA Delfino","year":"2007","unstructured":"Delfino VDA, Vianna ACD, Mocelin AJ, Barbosa DS, Mise RA, Matsuo T. Folic acid therapy reduces plasma homocysteine levels and improves plasma antioxidant capacity in hemodialysis patients. Nutrition. 2007;23(3):242\u20137.","journal-title":"Nutrition"},{"issue":"14","key":"1343_CR46","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.2174\/1389200222666211210153145","volume":"22","author":"AK Matsumoto","year":"2021","unstructured":"Matsumoto AK, Michelin AP, Seme\u00e3o LO, Sep\u00falveda-Loyola W, Pedr\u00e3o JVL, Porto GM, Arceni BS, Moreira EG, Delfino VDA, Barbosa DS. A Randomized Trial of Short-term Treatment with Folic Acid to Reduce the Oxidative Stress of Patients with Chronic Kidney Disease. Curr Drug Metab. 2021;22(14):1139\u201350.","journal-title":"Curr Drug Metab"},{"issue":"7","key":"1343_CR47","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1016\/S0735-1097(01)01235-9","volume":"37","author":"J Thambyrajah","year":"2001","unstructured":"Thambyrajah J, Landray MJ, Jones HJ, McGlynn FJ, Wheeler DC, Townend JN. A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease. J Am Coll Cardiol. 2001;37(7):1858\u201363.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1343_CR48","first-page":"33","volume":"7","author":"M Nafar","year":"2009","unstructured":"Nafar M, Khatami F, Kardavani B, Farjad R, Pour-Reza-Gholi F, Firouzan A, Kalantar A, Farhangi S, Einollahi B. Role of Folic Acid in Atherosclerosis After Kidney Transplant: A Double-blind, Randomized, Placebo-controlled Clinical Trial. Exp Clin Transplant. 2009;7(1):33\u20139.","journal-title":"Exp Clin Transplant"},{"key":"1343_CR49","first-page":"13","volume":"9","author":"F Sharifi","year":"2010","unstructured":"Sharifi F, Fakhrzadeh H, Mirarefin M, Pourebrahim R, Nouri M, Forouzanfar MH, Ghotbi S, Ghaderpanahi M, Larijani B. The effects of high-dose folic acid on blood pressure of hypertensive adults with hyperhomocysteinemia: A randomized double- blind placebo controlled clinical trial (Tehran homocysteine survey). Iran J Diabetes Lipid Disorders. 2010;9:13\u201320.","journal-title":"Iran J Diabetes Lipid Disorders"},{"issue":"5","key":"1343_CR50","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.arcmed.2009.06.004","volume":"40","author":"F Shidfar","year":"2009","unstructured":"Shidfar F, Homayounfar R, Fereshtehnejad SM, Kalani A. Effect of Folate Supplementation on Serum Homocysteine and Plasma Total Antioxidant Capacity in Hypercholesterolemic Adults under Lovastatin Treatment: A Double-blind Randomized Controlled Clinical Trial. Arch Med Res. 2009;40(5):380\u20136.","journal-title":"Arch Med Res"},{"issue":"1","key":"1343_CR51","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ijcard.2009.01.023","volume":"143","author":"G Ntaios","year":"2010","unstructured":"Ntaios G, Savopoulos C, Karamitsos D, Economou I, Destanis E, Chryssogonidis I, Pidonia I, Zebekakis P, Polatides C, Sion M, et al. The effect of folic acid supplementation on carotid intima-media thickness in patients with cardiovascular risk: a randomized, placebo-controlled trial. Int J Cardiol. 2010;143(1):16\u20139.","journal-title":"Int J Cardiol"},{"issue":"1","key":"1343_CR52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3109\/09637480903286371","volume":"61","author":"D Papandreou","year":"2010","unstructured":"Papandreou D, Malindretos P, Arvanitidou M, Makedou A, Rousso I. Homocysteine lowering with folic acid supplements in children: effects on blood pressure. Int J Food Sci Nutr. 2010;61(1):11\u20137.","journal-title":"Int J Food Sci Nutr"},{"issue":"9","key":"1343_CR53","first-page":"721","volume":"17","author":"T Stulc","year":"2001","unstructured":"Stulc T, Melenovsk\u00fd V, Grauov\u00e1 B, Kozich V, Ceska R. Folate supplementation prevents plasma homocysteine increase after fenofibrate therapy, Nutrition (Burbank, Los Angeles County. Calif). 2001;17(9):721\u20133.","journal-title":"Calif)"},{"issue":"1","key":"1343_CR54","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1159\/000057605","volume":"91","author":"H Trimarchi","year":"2002","unstructured":"Trimarchi H, Schiel A, Freixas E, D\u00edaz M. Randomized trial of methylcobalamin and folate effects on homocysteine in hemodialysis patients. Nephron. 2002;91(1):58\u201363.","journal-title":"Nephron"},{"issue":"10","key":"1343_CR55","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1093\/jn\/124.10.1927","volume":"124","author":"JB Ubbink","year":"1994","unstructured":"Ubbink JB, Vermaak WJH, Van der Merwe A, Becker PJ, Delport R, Potgieter HC. Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J Nutr. 1994;124(10):1927\u201333.","journal-title":"J Nutr"},{"key":"1343_CR56","doi-asserted-by":"crossref","unstructured":"Woodman RJ, Celermajer DE, Thompson PL, Hung J. Folic acid does not improve endothelial function in healthy hyperhomocysteinaemic subjects, Clinical science (London, England: 1979). 2004;106(4):353-358.","DOI":"10.1042\/CS20030296"},{"issue":"6","key":"1343_CR57","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.jacc.2005.10.064","volume":"47","author":"S Zoungas","year":"2006","unstructured":"Zoungas S, McGrath BP, Branley P, Kerr PG, Muske C, Wolfe R, Atkins RC, Nicholls K, Fraenkel M, Hutchison BG, Walker R, McNeil JJ. Cardiovascular Morbidity and Mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: A multicenter, randomized, controlled trial. J Am Coll Cardiol. 2006;47(6):1108\u201316.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"1343_CR58","doi-asserted-by":"publisher","first-page":"579","DOI":"10.2143\/AC.62.6.2024017","volume":"62","author":"H Yilmaz","year":"2007","unstructured":"Yilmaz H, Sahin S, Sayar N, Tangurek B, Yilmaz M, Nurkalem Z, Onturk E, Cakmak N, Bolca O. Effects of folic acid and N-acetylcysteine on plasma homocysteine levels and endothelial function in patients with coronary artery disease. Acta Cardiol. 2007;62(6):579\u201385.","journal-title":"Acta Cardiol"},{"issue":"8","key":"1343_CR59","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.ejim.2012.07.004","volume":"23","author":"HT Yang","year":"2012","unstructured":"Yang HT, Lee M, Hong KS, Ovbiagele B, Saver JL. Efficacy of folic acid supplementation in cardiovascular disease prevention: an updated meta-analysis of randomized controlled trials. Eur J Intern Med. 2012;23(8):745\u201354.","journal-title":"Eur J Intern Med"},{"issue":"7","key":"1343_CR60","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/j.clnu.2024.05.034","volume":"43","author":"N Zhang","year":"2024","unstructured":"Zhang N, Zhou Z, Chi X, Fan F, Li S, Song Y, Zhang Y, Qin X, Sun N, Wang X, Huo Y, Li J. Folic acid supplementation for stroke prevention: A systematic review and meta-analysis of 21 randomized clinical trials worldwide. Clin Nutr. 2024;43(7):1706\u201316.","journal-title":"Clin Nutr"},{"issue":"10","key":"1343_CR61","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.1007\/s12325-020-01474-z","volume":"37","author":"AD Kaye","year":"2020","unstructured":"Kaye AD, Jeha GM, Pham AD, Fuller MC, Lerner ZI, Sibley GT, Cornett EM, Urits I, Viswanath O, Kevil CG. Folic Acid Supplementation in Patients with Elevated Homocysteine Levels. Adv Ther. 2020;37(10):4149\u201364.","journal-title":"Adv Ther"},{"issue":"1","key":"1343_CR62","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41387-024-00282-6","volume":"14","author":"K Mokgalaboni","year":"2024","unstructured":"Mokgalaboni K, Mashaba GR, Phoswa WN, Lebelo SL. Folic acid supplementation on inflammation and homocysteine in type 2 diabetes mellitus: systematic review and meta-analysis of randomized controlled trials. Nutr Diabetes. 2024;14(1):22.","journal-title":"Nutr Diabetes"},{"issue":"5","key":"1343_CR63","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1007\/s00394-024-03344-8","volume":"63","author":"X Huang","year":"2024","unstructured":"Huang X, Bao H, Ding C, Li J, Cao T, Liu L, Wei Y, Zhou Z, Zhang N, Song Y, Chen P, Jiang C, Xie L, Qin X, Zhang Y, Li J, Sun N, Tang G, Wang X, Wang H, Huo Y, Cheng X. Optimal folic acid dosage in lowering homocysteine: Precision Folic Acid Trial to lower homocysteine (PFAT-Hcy). Eur J Nutr. 2024;63(5):1513\u201328.","journal-title":"Eur J Nutr"},{"issue":"13","key":"1343_CR64","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1080\/10408398.2021.1968787","volume":"63","author":"O Asbaghi","year":"2023","unstructured":"Asbaghi O, Salehpour S, Rezaei Kelishadi M, Bagheri R, Ashtary-Larky D, Nazarian B, Mombaini D, Ghanavati M, Clark CCT, Wong A, Naeini AA. Folic acid supplementation and blood pressure: a GRADE-assessed systematic review and dose-response meta-analysis of 41,633 participants. Crit Rev Food Sci Nutr. 2023;63(13):1846\u201361.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"2","key":"1343_CR65","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0369-8114(03)00104-4","volume":"51","author":"JC Guilland","year":"2003","unstructured":"Guilland JC, Favier A, de Courcy GP, Galan P, Hercberg S. Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease? 1. Basic data. Pathol Biol (Paris). 2003;51(2):101\u201310.","journal-title":"Pathol Biol (Paris)"},{"key":"1343_CR66","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cca.2020.11.013","volume":"512","author":"H Hou","year":"2021","unstructured":"Hou H, Zhao H. Epigenetic factors in atherosclerosis: DNA methylation, folic acid metabolism, and intestinal microbiota. Clin Chim Acta. 2021;512:7\u201311.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"1343_CR67","first-page":"7","volume":"80","author":"R Guieu","year":"2022","unstructured":"Guieu R, Ruf J, Mottola G. Hyperhomocysteinemia and cardiovascular diseases. Ann Biol Clin (Paris). 2022;80(1):7\u201314.","journal-title":"Ann Biol Clin (Paris)"},{"issue":"6","key":"1343_CR68","doi-asserted-by":"publisher","first-page":"102539","DOI":"10.1016\/j.cpcardiol.2024.102539","volume":"49","author":"F Fogacci","year":"2024","unstructured":"Fogacci F, Pizzi C, Bergamaschi L, Di Micoli V, Cicero AFG. Folic acid and plasma lipids: Interactions and effect of folate supplementation. Curr Probl Cardiol. 2024;49(6):102539.","journal-title":"Curr Probl Cardiol"},{"issue":"30","key":"1343_CR69","doi-asserted-by":"publisher","first-page":"8435","DOI":"10.1080\/10408398.2021.1928598","volume":"62","author":"O Asbaghi","year":"2022","unstructured":"Asbaghi O, Ashtary-Larky D, Bagheri R, Nazarian B, Pourmirzaei Olyaei H, Rezaei Kelishadi M, Nordvall M, Wong A, Dutheil F, Naeini AA. Beneficial effects of folic acid supplementation on lipid markers in adults: A GRADE-assessed systematic review and dose-response meta-analysis of data from 21,787 participants in 34 randomized controlled trials. Crit Rev Food Sci Nutr. 2022;62(30):8435\u201353.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"16","key":"1343_CR70","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1161\/CIRCULATIONAHA.110.000588","volume":"123","author":"AG Bostom","year":"2011","unstructured":"Bostom AG, Carpenter MA, Kusek JW, Levey AS, Hunsicker L, Pfeffer MA, Selhub J, Jacques PF, Cole E, Gravens-Mueller L, House AA, Kew C, McKenney JL, Pacheco-Silva A, Pesavento T, Pirsch J, Smith S, Solomon S, Weir M. Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial. Circulation. 2011;123(16):1763\u201370.","journal-title":"Circulation"},{"key":"1343_CR71","unstructured":"Angelini A, Cappuccilli ML, Magnoni G, Croci Chiocchini AL, Aiello V, Napoletano A, Iacovella F, Troiano A, Mancini R, Capelli I, Cianciolo G. The link between homocysteine, folic acid and vitamin B12 in chronic kidney disease. G Ital Nefrol. 2021;38(4)2021-vol4."},{"issue":"7","key":"1343_CR72","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1681\/ASN.2015030292","volume":"27","author":"N Bansal","year":"2016","unstructured":"Bansal N, Carpenter MA, Weiner DE, Levey AS, Pfeffer M, Kusek JW, Cai J, Hunsicker LG, Park M, Bennett M, Liu KD, Hsu CY. Urine Injury Biomarkers and Risk of Adverse Outcomes in Recipients of Prevalent Kidney Transplants: The Folic Acid for Vascular Outcome Reduction in Transplantation Trial. J Am Soc Nephrol. 2016;27(7):2109\u201321.","journal-title":"J Am Soc Nephrol"}],"container-title":["BMC Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40795-026-01343-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40795-026-01343-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40795-026-01343-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T11:03:31Z","timestamp":1786532611000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40795-026-01343-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1343"],"URL":"https:\/\/doi.org\/10.1186\/s40795-026-01343-y","relation":{},"ISSN":["2055-0928"],"issn-type":[{"value":"2055-0928","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"11 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"162"}}